MEDPLUS INC /OH/
DEF 14A, 1998-05-28
COMPUTER PERIPHERAL EQUIPMENT, NEC
Previous: CONTINENTAL CHOICE CARE INC, 8-K, 1998-05-28
Next: INLAND REAL ESTATE CORP, 424B3, 1998-05-28




SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the Securities 
Exchange Act of 1934 

Filed by the Registrant [X]

Filed by a Party other than the Registrant [ ]

Check the appropriate box:

[ ] Preliminary Proxy Statement

[ ] Confidential, for Use of the Commission Only (as permitted by 
Rule 14a-6(e)(2))

[X] Definitive Proxy Statement

[ ] Definitive Additional Materials

[ ] Soliciting Material Pursuant to Sec. 240.14a-11(c) or Sec. 240.14a-12

                          MedPlus, Inc.
      (Name of Registrant as Specified In Its Charter)


                               N/A
(Name of Person(s) Filing Proxy Statement if other than the 
                          Registrant)

Payment of Filing Fee (Check the appropriate box):

[X] No fee required.

[ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(1) 
and 0-11

1)  Title of each class of  securities to which transaction 
applies:
 
2)  Aggregate number of securities to which transaction applies:

3)  Per unit price or other underlying value of transaction 
computed pursuant to Exchange Act Rule 0-11 (Set forth the amount 
on which the filing fee is calculated and state how it was 
determined):

4)  Proposed maximum aggregate value of transaction:

5)  Total fee paid:

[ ] Fee paid previously with preliminary materials.

[ ] Check box if any part of the fee is offset as provided by 
Exchange Act Rule 0-11(a)(2) and identify the filing for which the 
offsetting fee was paid previously.  Identify the previous filing 
by registration statement number, or the Form or Schedule and the 
date of its filing.

1)  Amount Previously Paid:

2)  Form, Schedule or Registration Statement No.:

3)  Filing Party:

4)  Date Filed:

           

    MEDPLUS, INC.
            8805 Governor's Hill Drive, Suite 100
                   Cincinnati, Ohio 45249

          NOTICE OF ANNUAL MEETING OF SHAREHOLDERS

                                                   JUNE 25, 1998

TO THE SHAREHOLDERS OF MEDPLUS, INC.:

You are cordially invited to attend the Annual Meeting of the 
Shareholders of MedPlus, Inc. to be held on June 25, 1998 at 1:30 
P.M. at the Marriott Hotel Northeast, 9644 Mason-Montgomery Road, 
Mason, Ohio  45040, for the purpose of considering and acting on 
the following:

1.  Election of six directors to serve until the 1999 Annual 
Meeting.
 
2.  Approval of an amendment to the 1994 Long-Term Stock Incentive 
Plan increasing the total number of shares of the Company's Common 
Stock subject to grants thereunder from 1 million shares to 2 
million shares.
 
3.  Approval of the 1998 MedPlus, Inc. Employee Stock Purchase 
Plan.

4.  Transaction of such other business as may properly come before 
the meeting or any adjournment thereof.  

Shareholders of record at the close of business on May 11, 1998 
will be entitled to vote at the meeting.

                                By Order of the Board of Directors
                                  
                                Robert E. Kenny III
                                Secretary
May 22, 1998


__________________________________________________________________
                                                                  
                                IMPORTANT

A Proxy Statement and proxy are submitted herewith.  As a 
shareholder, you are urged to complete and mail the proxy promptly 
whether or not you plan to attend this Annual Meeting in person.  
The enclosed envelope for return of proxy requires no postage if 
mailed in the U.S.A. Shareholders attending the meeting may 
personally vote on all matters which are considered in which event 
their signed proxies are revoked.  It is important that your 
shares be voted.  In order to avoid the additional expense to the 
Company of further solicitation, we ask your cooperation in 
mailing your proxy promptly.
_________________________________________________________________



                           PROXY STATEMENT

                             MEDPLUS, INC.
                8805 Governor's Hill Drive, Suite 100
                       Cincinnati, Ohio  45249       
                                                     May 22, 1998

                  ANNUAL MEETING OF SHAREHOLDERS
                            June 25, 1998

                             INTRODUCTION

The enclosed form of proxy is being solicited on behalf of the 
Board of Directors of MedPlus, Inc. (also referred to as "MedPlus" 
or the "Company") for the Annual Meeting of Shareholders to be 
held on June 25, 1998.  Each of the 6,175,717 shares of Common 
Stock, without par value, outstanding on May 11, 1998, the record 
date of the meeting, is entitled to one vote on all matters coming 
before the meeting.  Only shareholders of record of the Company at 
the close of business on May 11, 1998 will be entitled to vote at 
the meeting either in person or by proxy.  This Proxy Statement is 
being mailed to shareholders on or about May 22, 1998.

The shares represented by all properly executed proxies which are 
sent to the Company will be voted as designated and each not 
designated will be voted affirmatively.  Each person granting a 
proxy may revoke it by giving notice to the Company's Secretary in 
writing or in open meeting at any time before it is voted.  
Proxies will be solicited principally by mail, but may also be 
solicited by directors, officers and other regular employees of 
the Company who will receive no compensation therefor in addition 
to their regular salaries.  Brokers and others who hold stock in 
trust will be asked to send proxy materials to the beneficial 
owners of the stock, and the Company will reimburse them for their 
expenses. The expense of soliciting proxies will be borne by the 
Company.

The Annual Report of the Company for the fiscal year ended January 
31, 1998 is enclosed with this Proxy Statement.

                      ELECTION OF DIRECTORS

Six directors are to be elected to hold office until the 1999 
Annual Meeting of Shareholders.  It is the intention of the 
individuals named in the proxy to vote for the election of only 
the six nominees named.  Only the maximum of six directors may be 
elected.  The Company is not currently aware of any potential 
candidates who may be nominated at or prior to the meeting, and in 
no event will the proxies solicited hereby be voted for other than 
the six nominees named.

The nominees, Richard A. Mahoney, Robert E. Kenny III, Paul J. 
Stein, Jay Hilnbrand, Paul  A. Martin and Philip S. Present II, 
are currently serving as members of the Board of Directors.  While 
management has no reason to believe that any of the nominees will, 
prior to the date of the meeting, refuse or be unable to accept 
the nominations, should any nominee so refuse or become unable to 
accept, the proxies will be voted for the election of such 
substitute nominee, if any, as may be recommended by the Board of 
Directors.  Nominees receiving the six highest totals of votes 
cast in the election will be elected as directors.  Proxies in the 
form solicited hereby which are returned to the Company will be 
voted in favor of the six nominees specified above unless 
otherwise instructed by the shareholders.  Abstentions and shares 
not voted by brokers and other entities holding shares on behalf 
of beneficial owners will not be counted and will have no effect 
on the outcome of the election.

Directors are elected annually and serve for one year terms.  
Information with respect to each of the six nominees is as 
follows:

Richard A. Mahoney, age 50, has been the Company's President and a 
director of the Company since January 1991.   While Mr. Mahoney 
has been the President of the Company since its inception, Mr. 
Mahoney has held the titles of Chairman of the Board and Chief 
Executive Officer of the Company since November 1995.

Robert E. Kenny III, age 42, an attorney engaged in the private 
practice of law since 1985, has served as Secretary of the Company 
since its inception and as a director of the Company since 1991.

Paul J. Stein, age 51, has been a director of the Company since 
1991.  Mr. Stein has been a self-employed marketing consultant and 
manufacturer's representative since October 1990. 

Jay Hilnbrand, age 64, a director of the Company since April 1994, 
is the General Manager of Universal Document Management Systems, 
Inc. ("UDMS"), a document management software development company 
which became a wholly-owned subsidiary of the Company in 1995.  

Paul A. Martin, age 43, a director of the Company since August 29, 
1996, has been an Implementation Consultant for the Company since 
August 18, 1997.  Prior to joining the Company, he had been the 
Corporate Accounts Receivable Manager for CommuniCare Health 
Services, a home healthcare agency which also owns and operates a 
nursing home, since 1995.  Prior to his position with CommuniCare 
he was the director of the business office for Dimensions Health 
Corp., a hospital and out-patient center management company.

Philip S. Present II, age 47, joined the Company in April 1995 as 
Vice President of Corporate Development.  Mr. Present was named 
the Chief Operating Officer of the Company in June 1996.  He 
became a director of the Company on December 13, 1997 to fill a 
vacancy created on the Board by an increase in the number of 
directors of the Company from five to six.  From September 1973 to 
March 1995, Mr. Present was employed by the certified public 
accounting firm of KPMG Peat Marwick LLP.  


            BOARD OF DIRECTORS MEETINGS AND COMMITTEES

In the fiscal year ended January 31, 1998, the Board of Directors 
met on two occasions.  Each  of Messrs. Mahoney, Kenny, Stein, 
Martin and Present attended 100% of the aggregate of (i) the total 
number of meetings of the Board of Directors (held during the 
period for which he has been a director) and (ii) the total number 
of meetings held by all committees of the Board on which he served 
(during the periods that he served).  Mr. Hilnbrand did not attend 
either meeting of the Board of Directors, but did execute the 
three Actions By Unanimous Written Consent of the Directors which 
were executed during the fiscal year ended January 31, 1998. 

The Company has an Audit Committee of the Board of Directors, the 
members of which are not officers or employees of the Company 
except for Messrs. Mahoney and Martin.  The Audit Committee, which 
held two meetings during the fiscal year ended January 31, 1998, 
recommends to the entire Board of Directors the independent 
auditors to be employed by the Company, consults with the 
independent auditors with respect to their audit plans, reviews 
the independent auditors' report and any management letters issued 
by the auditors, and consults with the independent auditors with 
regard to financial reporting and the adequacy of internal 
controls.  The members of the Audit Committee during the fiscal 
year ended January 31, 1998 were Messrs. Mahoney, Kenny, Stein and 
Martin.

The Company has a Compensation Committee of the Board of 
Directors, which held two meetings and executed four Actions by 
Unanimous Written Consent during the fiscal year ended January 31, 
1998. The Compensation Committee recommends to the entire Board of 
Directors the compensation arrangements, including grants of stock 
options and other incentives under the Company's 1994 Long-Term 
Stock Incentive Plan, for the corporate officers of the Company 
and reviews proposed changes in management organization.  The 
present members of the Compensation Committee are Messrs. Stein 
and Kenny.  Mr. Martin resigned from the Compensation Committee on 
August 15, 1997 upon becoming an employee of the Company.


                      SECURITY OWNERSHIP OF
            CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

Certain Beneficial Owners

Under Section 13(d) of the Securities Exchange Act of 1934 and the 
rules promulgated thereunder, a beneficial owner of a security is 
any person who, directly or indirectly, has or shares voting power 
or investment power over such security.  Such beneficial owner 
under this definition need not enjoy the economic benefit of such 
securities.  The following shareholders are known by the Company 
to have been the beneficial owners of 5% or more of the Company's 
Common Stock as of January 31, 1998:     


Title of     Name and Address of   Amount and Nature  Percent
Class        Beneficial Owner(1)   of Ownership       of Class(2)
____________ ____________________  _________________  ___________

Common Stock Richard A. Mahoney       3,051,974 shares    47.52%
             Chairman of the Board,   owned 
             President and Chief      beneficially (3)
             Executive Officer
             8598 Twilight Tear Drive
             Cincinnati, OH  45249     

Common Stock The Keys Plus            690,938 shares      11.22%
             Irrevocable Trust        owned
             8598 Twilight Tear Drive beneficially (4) 
             Cincinnati, OH  45249     

Common Stock The Keys                 690,937 shares      11.22%
             Irrevocable Trust        owned
             8598 Twilight Tear Drive beneficially (4) 
             Cincinnati, OH  45249     

Common Stock Paul J. Stein            310,250 shares       5.03%
             4041 Harding Drive       owned
             Westlake, OH  44148      beneficially (5)
_____________________                
(1)  The persons and entities named in the above table had, at 
January 31, 1998, sole voting and investment power with respect to 
all shares of Common Stock shown as beneficially owned by them, 
subject to community property laws where applicable and the 
information contained in other footnotes to this table. For 
purposes of this table, stock options were considered to be 
exercisable if by their terms they could have been exercised as of 
January 31, 1998 or if they became exercisable within 60 days 
thereafter.  

(2)  Percentages indicated for each person are calculated with 
respect to a total number of shares equal to the number of shares 
actually outstanding as of January 31, 1998 plus that number of 
shares which such person had the right to acquire as of the date 
60 days thereafter.
 
(3)  Total consists of 927,725 owned outright by Mr. Mahoney, 
4,500 shares owned by members of Mr. Mahoney's immediate family 
and 250,000 shares subject to options exercisable by Mr. Mahoney 
as of January 31, 1998 or within 60 days thereafter.  In addition,

Mr. Mahoney is the sole trustee of two trusts for the benefit of 
certain minor children which at January 31, 1998 held a total of 
1,381,875 shares of Common Stock; Mr. Mahoney had, and continues 
to have, sole voting and dispository power with respect to the 
shares held by the trusts but no pecuniary interest in such 
shares.  Finally, Mr. Mahoney had sole voting power as proxy with 
respect to an additional 487,874 shares, 11,250 of which were 
shares subject to options exercisable at January 31, 1998 or 
within 60 days thereafter.
 
(4)  These shares are also included in the shares shown as 
beneficially owned by Mr. Mahoney.
 
(5)  Total consists of (i) 274,000 shares owned outright by Mr. 
Stein, (ii) 30,000 shares owned by members of Mr. Stein's 
immediate family and (iii) 6,250 shares which Mr. Stein then had, 
and continues to have, the option to purchase.  Mr. Stein had, and 
continues to have, shared voting and investment power with respect 
to the shares owned by members of his immediate family.  Mr. 
Mahoney had, and continues to have, sole voting power as a proxy 
with respect to the 274,000 shares owned outright by Mr. Stein and 
the 6,250 shares which Mr. Stein had the option to purchase; 
accordingly, these shares are also included in the shares shown as 
beneficially owned by Mr. Mahoney.

Management          

The following table sets forth the beneficial ownership of the 
Company's Common Stock by its directors, the named executives and 
all directors and executive officers as a group, as of May 11, 
1998:


Title of      Name and Position of   Amount and Nature   Percent
Class         Beneficial Owner(1)    of Ownership        of Class
____________  ______________________ __________________  ________
                                                            
Common Stock  Richard A. Mahoney       3,044,474 shares    47.28%
              Chairman of the Board,   owned
              President, Chief         beneficially 
              Executive Officer and
              Director                     
                                                              
Common Stock  Paul J. Stein            312,750 shares       5.06%
              Director                 owned 
                                       beneficially(3)            
                                                            
Common Stock  Gary L. Price            102,800 shares       1.66%
              Senior Vice President,   owned
              Business Development     beneficially           
                                                            
Common Stock  Jay Hilnbrand            95,724 shares        1.55%
              Director and             owned
              General Manager          beneficially(4)
              of Subsidiary
                                                            
Common Stock  Philip S. Present II     88,829 shares        1.43%
              Chief Operating Officer  owned
              and Director             beneficially(5)            
                                                
Common Stock  Timothy P. McMullen      30,001 shares        0.48%
              Vice President of Sales  owned
              and Marketing            beneficially(6)            
                                                            
Common Stock  Paul F. Albrecht         23,384 shares        0.38%
              Vice President and       owned
              Chief Technology Officer beneficially(7)
                                                            
Common Stock  Robert E. Kenny III      14,250 shares        0.23%
              Director and Secretary   owned                  
                                       beneficially(8)
                                                            
Common Stock  Paul A. Martin           3,388 shares         0.05%
              Director and             owned
              Implementation           beneficially(9) 
                                                            
Common Stock  All directors and        3,363,229 shares    51.12%
              executive officers       owned
              as a group(10 persons)   beneficially(10)
_________________________
(1)  The persons and entities named in the above table have sole 
voting and investment power with respect to all shares of Common 
Stock shown as beneficially owned by them, subject to community 
property laws where applicable and the information contained in 
other footnotes to this table. For purposes of this table, stock 
options are considered to be currently exercisable if by their 
terms they may be exercised as of May 11, 1998 or if they become 
exercisable within 60 days thereafter.  
 
(2)  Total consists of (i) 927,725 shares which are owned outright 
by Mr. Mahoney, (ii) 4,500 shares which are owned by members of 
Mr. Mahoney's immediate family, (iii) 1,381,875 shares which are 
owned by Mr. Mahoney as trustee for the benefit of certain minor 
children and with respect to which Mr. Mahoney has sole voting and 
dispository power, (iv) 480,374 shares, 13,750 shares of which are 
shares subject to options exercisable on or before July 10, 1998, 
as to which Mr. Mahoney has sole voting power as proxy and (v) 
250,000 shares which Mr. Mahoney currently has the option to 
purchase pursuant to options granted to him in 1995, 1996 and 1997 
in accordance with his employment agreement with the Company, and 
options granted to him in lieu of a cash bonus for 1996.
 
(3)  Total consists of (i) 274,000 shares owned outright by Mr. 
Stein, (ii) 30,000 shares which are owned by members of Mr. 
Stein's immediate family and (iii) 8,750 shares which Mr. Stein 
currently has the option to purchase or will have the option to 
purchase on or before July 10, 1998.  Mr. Stein has shared voting 
and investment power with respect to the shares owned by members 
of his immediate family.  Mr. Mahoney has sole voting power as a 
proxy with respect to the 274,000 shares owned outright by Mr. 
Stein and, should Mr. Stein choose to exercise his option to 
purchase 8,750 shares, Mr. Mahoney will also have sole voting 
power as a proxy with respect to those shares.  Accordingly, the 
274,000 shares owned outright by Mr. Stein and the 8,750 shares 
which Mr. Stein has the option to purchase as of are also included 
in the shares shown as beneficially owned by Mr. Mahoney.
 
(4)  Total consists of (i) 90,724 shares owned outright by Mr. 
Hilnbrand and (ii) 5,000 shares which Mr. Hilnbrand has the option 
to purchase or will have the option to purchase on or before July 
10, 1998.   Mr. Mahoney has sole voting power as a proxy with 
respect to the 90,724 shares owned outright by Mr. Hilnbrand and, 
should Mr. Hilnbrand choose to exercise his option to purchase 
5,000 shares, Mr. Mahoney will also have sole voting power as a 
proxy with respect to those shares.  Accordingly, all shares shown 
as beneficially owned by Mr. Hilnbrand are also included in the 
shares shown as beneficially owned by Mr. Mahoney.
 
(5)  Total consists of (i) 30,000 shares owned by Mr. Present 
through a retirement plan account, (ii) 53,334 shares which Mr. 
Present has the option to purchase and (iii) approximately 5,495 
shares held by Mr. Present through the MedPlus, Inc. 401(k) Plan. 
 
(6)  Total consists of 30,001 shares which Mr. McMullen has the 
option to purchase.
 
(7)  Total consists of 23,834 shares which Mr. Albrecht has the 
option to purchase.
 
(8)  Total consists of (i) 5,000 shares owned outright by Mr. 
Kenny, (ii) 500 shares which Mr. Kenny owns through an IRA and 
(iii) 8,750 shares which Mr. Kenny has the option to purchase or 
will have the option to purchase on or before July 10, 1998.
 
(9)  Total consists of 3,388 shares which Mr. Martin has the 
option to purchase.

(10)  Includes the shares owned by Mr. Mahoney as a trustee, 
shares over which Mr. Mahoney has voting power and shares owned by 
Mr. Stein's immediate family and the total number of shares owned 
directly by all directors and executive officers, including those 
officers who are not named executives.

The Company's executive officers not previously discussed under 
"Election of Directors" are as follows:

Gary L. Price, 43,  joined the Company as Vice President, Sales in 
January 1992 and in June 1996 was named Senior Vice President, 
Business Development.

Timothy P. McMullen, 43, has been the Vice President of Sales and 
Marketing since December 13, 1997.  He joined the Company as Vice 
President, Corporate Accounts and Managed Care in June 1996 after 
sixteen years with the Hill-Rom Co. Inc.  At Hill-Rom, the world's 
largest manufacturer and distributor of patient beds and patient 
environments, he held several senior positions including Vice 
President of Corporate Accounts, Merchandising, International, and 
Domestic Sales.
 
Daniel A. Silber, 49, joined the Company as Vice President of 
Finance and Chief Financial Officer in May 1995.  From 1993 until 
he joined the Company, he was Chief Financial Officer for Saturday 
Knight LTD, a manufacturer and distributor of bathroom 
accessories.

Paul F. Albrecht, 43, was elected Vice President and Chief 
Technology Officer on December 13, 1997 following his tenure as 
General Manager of the ChartMaxx(tm) Division of MedPlus since May 
16, 1994.  Prior to joining the Company, Mr. Albrecht had been the 
Director of the Systems Development Area for Cincinnati Bell 
Information Systems since December 1991.

     AMENDMENT TO 1994 MEDPLUS, INC. LONG-TERM STOCK
                       INCENTIVE PLAN 

     A key factor in the Company's continuing advancement and 
growth is its ability to attract, motivate and retain highly 
qualified employees.  The market for such employees, especially in 
the Company's high technology industry, continues to be extremely 
competitive.  The Company has historically utilized stock-based 
incentives to attract, motivate and retain employees and hopes to 
continue to do so.  Because a number of the companies with which 
the Company and its subsidiaries compete for employees make 
extensive use of stock-based incentives to maintain a highly 
qualified employee base, the Company believes that stock-based 
incentives enable the Company to cost-effectively compete for the 
talents of key employees.  In addition, the Company believes that 
by providing its employees with the opportunity to purchase the 
Company's Common Stock at attractive prices, it is giving 
employees a chance at a long-term ownership stake in the Company; 
as a result, the economic interests of the Company's employees and 
those of its shareholders are aligned.

For the above reasons, the Company has in place the 1994 MedPlus, 
Inc. Long-Term Stock Incentive Plan (the "Long-Term Plan").  
Subject to the provisions of the Long-Term Plan, a Committee of 
the Board of Directors designated to administer the Long-Term Plan 
(the "Committee") may at any time, or from time to time, grant 
stock incentives under the Long-Term Plan to, and only to, those 
employees who in the opinion of the Committee can contribute 
significantly to the growth and successful operations of the 
Company or a Subsidiary ("Eligible Employees").  Stock incentives 
may be granted in the form of a stock option ("Option"), a stock 
appreciation right ("SAR"), a stock award ("Stock Award"), or a 
combination of an Option, a SAR, and/or a Stock Award.

The Board of Directors believes that additional shares of Common 
Stock should be available for issuance by the Board from time to 
time to Eligible Employees pursuant to the Long-Term Plan.  As of 
May 11, 1998, all of the currently authorized 1,000,000 shares of 
Common Stock subject to stock incentives which may be granted 
under the Long-Term Plan had been granted.  Thus, the Board has 
approved, and recommends the shareholders adopt, an amendment to 
the Long-Term Plan which increases the number of shares of Common 
Stock which the Board is authorized to issue thereunder from 
1,000,000 to 2,000,000 shares.

The maximum amount of Common Stock with respect to which stock 
incentives may be granted to any person during any calendar year 
(the "Maximum Annual Grant") is 50,000 shares; provided, however, 
that in the case of a grant made to a recipient upon the 
recipient's initial hiring by the Company or in lieu of a cash 
bonus, the Maximum Annual Grant is increased to 100,000 shares.

Shares of Common Stock subject to stock incentives granted under 
the Long-Term Plan may be either authorized but unissued shares or 
shares held in the Company's treasury, or any combination thereof, 
in the discretion of the Committee. The number of shares of Common 
Stock which may be granted under the Long-Term Plan as Stock 
Awards in any calendar year may not exceed 25,000. 

The Long-Term Plan is administered by the Committee which consists 
of not less than three directors of the Company designated by the 
Board of Directors in accordance with the Code of Regulations of 
the Company; provided, however, that no director may be designated 
as or continue to be a member of the Committee unless such 
director is at the time of designation and service a 
"disinterested person" within the meaning of Rule 16b-3 of the 
Securities and Exchange Commission (or any successor provision at 
the time in effect).  Grants of stock incentives may be 
recommended by the Committee either with or without consultation 
with employees, but the Committee has full authority to act in the 
matter of selection of all Eligible Employees and in recommending 
stock incentives to be granted to them.

The Long-Term Plan may be amended by the Board of Directors upon 
the recommendation of the Committee, provided that, without the 
approval of the shareholders of the Company, no amendment shall be 
made which (i) increases the maximum aggregate number of shares of 
Common Stock that may be issued or transferred pursuant to stock 
incentives, (ii) withdraws the administration of the Long-Term 
Plan from the Committee or amends the provisions of the Long-Term 
Plan with respect to eligibility and disinterest  of members of 
the Committee, (iii) permits any person who is not at the time an 
Eligible Employee of the Company or of a subsidiary to be granted 
a stock incentive, (iv) permits any Option to be exercised more 
than ten years after the date it is granted, (v) amends the Long-
Term Plan to extend the date set forth therein for shareholder 
approval or (vi) amends the provisions governing the amendment 
process.  However, the Board of Directors may by resolution, 
adopted by a majority of the entire Board of Directors, 
discontinue the Long-Term Plan.  No amendment or discontinuance of 
the Long-Term Plan by the Board of Directors or the shareholders 
of the Company will, without the consent of the employee, 
adversely affect any stock incentive previously granted to such 
employee.

     On May 11, 1998, the closing price of the Company's Common 
Stock on the Nasdaq National Market was $7.13.

     PROPOSAL TO ADOPT THE 1998 MEDPLUS, INC. EMPLOYEE STOCK      
                        PURCHASE PLAN

     As noted above, the Company's success in attracting, 
motivating and retaining highly qualified employees is partially 
due to its use of stock-based incentives.  To date, the Company 
has been using the Long-Term Plan to provide stock incentives to 
key employees.  However, in an effort to further motivate and 
retain its current employees and to attract talented individuals, 
the Company now believes that it is appropriate to adopt the 1998 
MedPlus, Inc. Employee Stock Purchase Plan (the "1998 Plan").

     On April 23, 1998, the Board of Directors approved, subject 
to shareholder approval, the adoption of the 1998 Plan.  The 1998 
Plan will be submitted for shareholder approval at the Annual 
Meeting.  The full text of the 1998 Plan is attached as Exhibit A 
to this Proxy Statement, and the following discussion is qualified 
in its entirety by reference to Exhibit A.

     In approving the 1998 Plan for submission to the Company's 
shareholders, the Board of Directors recognized the changing 
environment for the compensation of eligible employees.  To 
provide a flexible vehicle under which appropriate benefits can be 
obtained by employees, the 1998 Plan permits employees to acquire 
a proprietary interest in the Company through the purchase of 
shares of the Company's Common Stock at a price which is the lower 
of 85% of the closing price of the stock on the Offering 
Commencement Date (as defined in the 1998 Plan) or the Offering 
Termination Date (as defined in the 1998 Plan), subject to 
additional restrictions described below and in Exhibit A.

     The 1998 Plan will become effective on August 1, 1998 if 
approved and adopted by the shareholders and shares subject to the 
1998 Plan will be registered by the Company on a Registration 
Statement on Form S-8.  If the 1998 Plan is not approved by the 
shareholders, the 1998 Plan will be of no force and effect.  If 
approved, the 1998 Plan will continue in existence until July 31, 
2002, unless earlier terminated by the Board of Directors.  The 
Board of Directors may terminate the 1998 Plan at any time.  In 
addition, subject to the provisions of the 1998 Plan, a Committee 
of the Board of Directors designated to administer the 1998 Plan 
(the "1998 Plan Committee") shall have plenary authority in its 
discretion to interpret and construe the provisions of the 1998 
Plan and adopt rules and regulations for administering the 1998 
Plan.

     Subject to certain restrictions as to the number of shares 
each employee may purchase under the 1998 Plan, any employee who 
(1) is regularly scheduled to work more than 20 hours per week, 
(2) has completed 90 days' employment and (3) is employed by the 
Company on the date the employee's participation in the 1998 Plan 
is to become effective will be eligible to participate in 
offerings under the 1998 Plan which commence on or after such 90 
day period has concluded.  The Company currently has approximately 
114 such employees.  An eligible employee may become a participant 
by authorizing a payroll deduction for such participation in 
accordance with the 1998 Plan.

     The 1998 Plan will be implemented by four annual offerings of 
the Company's Common Stock beginning on the 1st day of August in 
each of the years 1998, 1999, 2000 and 2001, each Offering  (as 
defined in the 1998 Plan) terminating on July 31 of the following 
year, provided, however, that each annual Offering may, in the 
discretion of the 1998 Plan Committee exercised prior to the 
commencement thereof, be divided into two six-month Offerings 
commencing, respectively, on August 1 of such year and February 1 
of the following year and terminating on January 31 and July 31 of 
the following year, respectively.  The maximum number of shares 
which may be issued under the 1998 Plan is 350,000.  The number of 
shares which may be issued in each Offering is indicated in detail 
in Exhibit A hereto.

     The Board of Directors shall have complete power and 
authority to terminate or amend the 1998 Plan; provided, however, 
that the Board of Directors shall not, without the approval of the 
shareholders of the Corporation (i) increase the maximum number of 
shares which may be issued under any Offering (except pursuant to 
Section 12.04 of the 1998 Plan); (ii) amend the requirements as to 
the class of employees eligible to purchase stock under the 1998 
Plan or (iii) permit the members of the Committee to purchase 
stock under the 1998 Plan. No termination, modification, or 
amendment of the 1998 Plan may, without the consent of an employee 
then having an option under the 1998 Plan to purchase stock, 
adversely affect the rights of such employee under such option.

Federal Income Tax Consequences

It is the intention of the Company to have the 1998 Plan qualify 
as an "employee stock purchase plan" under Section 423 of the 
Internal Revenue Code of 1986, as amended (the "Code").  The 1998 
Plan has been structured in order to meet the criteria of Section 
423 of the Code.  No taxable income for federal income tax 
purposes results to an employee from the exercise of the option to 
purchase shares of stock under the 1998 Plan.  Any gain realized 
on the sale of stock acquired through the 1998 Plan is considered 
as capital gain for federal income tax purposes to an employee if 
the stock has been held at least one year after it was acquired 
and if at least two years have expired from the grant of the 
option.  Any appreciation is considered a long-term capital gain 
to the employee if the stock was held longer than eighteen months 
from the date of acquisition.  The Company is not entitled to any 
deduction for federal income tax purposes with respect to the 
grant or exercise of any option under the 1998 Plan. 

                    NEW PLAN BENEFITS

Except as reflected in the following table, no specific 
determinations have been made or can be made in advance as to the 
future recipients of stock incentives under the Long-Term Plan or 
of benefits under the 1998 Plan.  The table sets forth known 
future grants under the Long-Term Plan and the 1998 Plan, if any. 
The information in this table is subject to change in light of 
facts and circumstances that may occur in the future but are not 
presently known to the Company.

<TABLE>

      <CAPTION>                                         1994 Long Term            1998 Employee Stock 
                                                      Stock Incentive Plan            Purchase Plan
                                                ____________________         ___________________

Name and Position         Dollar Value ($)      Number of Units (1)          Number of Units (1)
__________________        _________________     ____________________         ___________________            
<S>                             <C>                    <C>                           <C>
Richard A. Mahoney, 
Chairman of the Board, 
President and Chief 
Executive Officer               --(2)                  200,000(3)                    --(4)           
               
Gary L. Price, 
Vice President, Sales             --                       --                        --
             
Philip S. Present II,
Chief Operating Officer
and Director                    --(2)                   50,000(5)                    --           
              
Timothy P. McMullen, 
Vice President, Sales 
and Marketing                     --                       --                        --

Paul F. Albrecht, 
Chief Technology Officer          --                       --                        --
          
Executive Officer Group         --(2)                  250,000                       --
          
Non-Executive Director Group      --                       --                        --

Non-Executive Officer 
Employee Group                  --(2)                   65,000(6)                    --
__________________________          

</TABLE>                                     


(1) Units referenced are of options.
(2) Due to the nature of options, the options listed cannot be 
valued at this time.
(3) Mr. Mahoney is entitled to annual 50,000 share option grants 
pursuant to his employment agreement. The term of the employment 
agreement expires June 30, 2001.  Such grants are subject to Mr. 
Mahoney's continued employment with the Company. See "Executive 
Compensation -- Employment Agreements."  Of the 200,000 options to 
be granted to Mr. Mahoney, the receipt of 50,000 options which 
have been granted to Mr. Mahoney is contingent upon the approval 
by the shareholders of the proposed amendment to the 1994 MedPlus, 
Inc. Long-Term Stock Incentive Plan. 
(4) Because Mr. Mahoney is the beneficial owner of greater than 5% 
of the Company's outstanding common stock, he will be unable to 
participate in the 1998 Plan in accordance with its terms.
(5) Mr. Present is entitled to a 50,000 share option grant if he 
is elected President of the Company during his employment with the 
Company.  See "Executive Compensation - Employment Agreements."  
(6) Of the 65,000 options to be granted to non-executive officer 
employees, 60,000 are options which have been granted to such 
employees contingent upon the approval by the shareholders of the 
proposed amendment to the 1994 MedPlus, Inc. Long-Term Stock 
Incentive Plan. 


              Approval by Shareholders

The resolution which will be introduced at the Annual Meeting 
seeking approval of an amendment to the Long-Term Plan is as 
follows:

RESOLVED, that Section 4(a) of the 1994 Long-Term Stock Incentive 
Plan be amended to read in its entirety as follows:

"(a)  The maximum aggregate number of shares of Common Stock 
subject to Stock Incentives that may be granted to participants in 
the Plan shall be 2,000,000.  Shares of Common Stock subject to 
Stock Incentives granted under this Plan may be either authorized 
but unissued shares or shares held in the Company's treasury, or 
any combination thereof, in the discretion of the Committee."

Adoption of the above resolution requires the affirmative vote of 
the holders of a majority of the Company's Common Stock present in 
person or by proxy at the Annual Meeting and entitled to vote.  
Proxies in the form solicited hereby which are returned to the 
Company will be voted in favor of the resolutions unless otherwise 
instructed by the shareholders.  Abstentions and shares not voted 
by brokers and other entities holding shares on behalf of 
beneficial owners will have the same effect as votes cast against 
the resolutions, provided such shares are properly present at the 
meeting in person or by proxy. 

The resolution which will be introduced at the Annual Meeting 
seeking approval of the adoption of the 1998 Plan is as follows:

RESOLVED, that the MedPlus, Inc. 1998 Employee Stock Purchase Plan 
be, and it hereby is, adopted in the form attached as Exhibit A to 
the Proxy Statement relating to this Annual Meeting of 
Shareholders.


Adoption of the above resolution requires the affirmative vote of 
the holders of a majority of the Company's Common Stock present in 
person or by proxy at the Annual Meeting and entitled to vote.  
Proxies in the form solicited hereby which are returned to the 
Company will be voted in favor of the resolutions unless otherwise 
instructed by the shareholders.  Abstentions and shares not voted 
by brokers and other entities holding shares on behalf of 
beneficial owners will have the same effect as votes cast against 
the resolutions, provided such shares are properly present at the 
meeting in person or by proxy. 


                    EXECUTIVE COMPENSATION

Summary


The following table summarizes, for the fiscal years indicated, 
all annual compensation earned by or granted to the Company's 
Chief Executive Officer and the four most highly-compensated 
executive officers, other than the Chief Executive Officer, whose 
compensation exceeded $100,000 for all services rendered to the 
Company in all capacities (the "named executives") during the last 
fiscal year and who were serving in such capacity as of January 
31, 1998:


<TABLE>
                                            SUMMARY COMPENSATION TABLE

<CAPTION>                                                           Long Term Compensation
                                                         _______________________________________
                           Annual Compensation                    Awards          
                         __________________________________   __________________________
Name and                                        Other Annual   Restricted     Securities  All Other
Principal           Fiscal                      Compensa-      Stock          Underlying  Compensa-
Position            Year(1)  Salary($) Bonus($) tion($)        Awards($)      Options(#)  tion($)   
_____________       _______  _________ ________ _____________  __________     __________  __________
<S>                  <C>     <C>       <C>           <C>         <C>          <C>          <C>
Richard A. Mahoney,  1998    205,004   200,000       --          4,015         50,000(1)       --
Chairman of the 
Board, President     1996    200,750      --         --            --         100,000          --
and Chief Executive 
Officer              1995    137,000    63,000       --            --          50,000

Gary L. Price,       1998    132,541    68,088(2)    --          4,015            --       21,420(3)
Senior Vice 
President,           1996    112,500    95,461       --            --             --           --
Business 
Development          1995     98,000   126,486       --            --             --           --

Timothy P. McMullen, 1998    149,583    28,262(2)    --            --          25,000(1)       --
Vice President of
Sales and            1996     78,750      --         --            --          50,000          --
Marketing 
                     1995       --        --         --            --             --           --

Philip S. Present,   1998    151,649   100,000       --            --             --(1)        --
II, Chief Operating 
Officer and          1996    128,000      --         --            --          30,000          --
Director 
                     1995     69,000      --         --            --          25,000          --

Paul F. Albrecht,    1998     96,667      --         --            --          20,000(1)       --
Vice President and
Chief Technology     1996     75,000      --         --            --          15,000          --
Officer           
                     1995     72,000      --         --            --          10,000          --

_______________
</TABLE>


(1) In December 1997, the Company changed its fiscal year end from 
December 31 to January 31.  Accordingly, the Company's 1998 fiscal 
year commenced on February 1, 1997 and ended on January 31, 1998. 
 Information for the year ended January 31, 1998 is compared with 
information for the years ended December 31, 1995 and December 31, 
1996.   During the period from January 1 through January 31, 1997, 
Mr. Mahoney earned a salary of $24,750 and was granted 50,000 
options, Mr. Price earned a salary of $16,500, Mr. McMullen earned 
a salary of $11,250 and was granted 5,000 options, Mr. Present 
earned a salary of $18,000 and was granted 25,000 options and Mr. 
Albrecht earned a salary of $10,500 and was granted 1,500 options. 
This information is not included in the table and no additional 
compensation of any type was earned by the named executive 
officers during that period.
(2) Amounts indicated represent commission payments.
(3) Amount indicated represents the forgiveness of a loan made to 
Mr. Price in the amount of $21,420.


Stock Options

The following table sets forth information regarding stock options 
granted to the named executives during fiscal year 1998:

                 OPTION GRANTS IN LAST FISCAL YEAR

                           Individual Grants
__________________________________________________________________
              Number of    % of Total 
              Securities   Options         Exercise     
              Underlying   Granted to      of Base   Expira-
              Options      Employees in    Price     tion
Name          Granted      Fiscal year     ($/Sh.)   Date
_____________ ___________  ______________  _________ _____________
Richard A. 
Mahoney        50,000(1)        19%          5.63   April 15, 2002

Gary L. Price     --            --            --           --

Timothy P. 
McMullen       25,000(2)         9%          6.31     May 15, 2002

Philip S. 
Present II        --(3)         --             --          --

Paul F.
Albrecht       20,000(4)         7%          6.31     May 15, 2002


(1) During the period from January 1 through January 31, 1997, Mr. 
Mahoney was granted 50,000 options at an exercise price of $5.13 
per share which represents 29% of the total options granted to all 
employees of the Company during such period.  These options expire 
January 7, 2002.
(2) During the period from January 1 through January 31, 1997, Mr. 
McMullen was granted 5,000 options at an exercise price of $5.13 
per share which represents 3% of the total options granted to all 
employees of the Company during such period. These options expire 
January 7, 2002.
(3) During the period from January 1 through January 31, 1997, Mr. 
Present was granted 25,000 options at an exercise price of $5.13 
per share which represents 15% of the total options granted to all 
employees of the Company during such period. These options expire 
January 7, 2002.
(4) During the period from January 1 through January 31, 1997, Mr. 
Albrecht was granted 1,500 options at an exercise price of $5.13 
per share which represents 1% of the total options granted to all 
employees of the Company during such period. These options expire 
January 7, 2002.


<TABLE>

The following table sets forth information regarding stock options exercised by the named executives during 
fiscal year 1998 and the value of unexercised in-the-money options held by the named parties as of January 
31, 1998:

<CAPTION>
                                 AGGREGATED OPTION EXERCISES IN LAST FISCAL YEAR
                                             AND FY-END OPTION VALUES
  
                                                   Number of Securities
                                                 Underlying Unexercised      Value of Unexercised In-the-
                                                  Options at FY-End(#)      Money Options at FY-End($)(1)
                                             __________________________   _______________________________
                               Shares
                             Acquired on    Value                           
Name                  Exercise    Realized($)   Exercisable  Unexercisable    Exercisable      Unexercisable
__________________    _________   ___________   ___________  ______________   ____________     _____________
<S>                       <C>        <C>          <C>           <C>              <C>                <C>
Richard A. Mahoney        --         --           25,000           --            521,500             --    

Gary L. Price             --         --             --             --               --               --

Timothy P. McMullen       --         --           11,667        68,333             6,768            85,532

Philip S. Present II      --         --           43,335        36,665            77,020            91,280

Paul F. Albrecht          --         --           12,167        34,333             2,030            57,600


___________________

</TABLE>





(1) Based on the average high and low prices of the Company's 
common stock on January 30, 1998.
 
Compliance with Section 16(a) of the Exchange Act

     To the Company's knowledge, during fiscal year 1998, all 
reports required to be filed under Section 16(a) of the Exchange 
Act were filed in a timely manner.

Compensation of Directors

During the year ended January 31, 1998, the Company's outside 
directors (those directors who are not employees of the Company) 
were compensated for their services as directors as follows:  (i) 
director Paul A. Martin was compensated at the rate of $500 per 
meeting prior to his employment with the Company and (ii) 
directors Paul J. Stein and Robert E. Kenny III were compensated 
at the rate of $3,000 per meeting; $2,500 of each $3,000 payment 
made to Messrs. Stein and Kenny represented forgiveness of amounts 
due under promissory notes issued to the Company by Messrs. Stein 
and Kenny for loans made to them by the Company to purchase shares 
of the Company's Common Stock (outside directors are not 
compensated for committee meetings that occur on the same date as 
full Board meetings).  The Company does not additionally 
compensate employee directors.  All directors are reimbursed for 
all expenses incurred in connection with attendance at meetings of 
the Board and the performance of Board duties.

In addition, outside directors are entitled to receive stock 
options under the Directors' Plan.  The Directors' Plan provides 
that, commencing in 1995, nonemployee directors were entitled to 
an option to purchase 5,000 shares after their first year in 
office and to an annual, automatic grant of an option to purchase 
2,500 shares of the Company's Common Stock at every annual 
shareholders' meeting commencing in 1995.  A total of 100,000 
shares is available under the Directors' Plan.  All options 
granted under the Directors' Plan have a five year term and an 
exercise price equal to 100% of fair market value of the Common 
Stock on the date of issuance.  Options are not exercisable at all 
for six months after their issuance, at which time they become 
exercisable as to 50% of the shares covered.  After 12 months, 
they become exercisable in full until expiration. 

Employment Agreements

Richard A. Mahoney, the Company's Chairman of the Board, President 
and Chief Executive Officer, is employed pursuant to an employment 
agreement dated October 31, 1995.  The term of the agreement 
expires on June 30, 2001 and commenced on November 1, 1995.  It 
provides for a base salary of $186,000 per annum initially, 
increasing incrementally to a base salary of $245,000 per annum in 
the final year of the agreement.  Under the agreement, Mr. Mahoney 
will also be entitled to annual bonuses of up to 100% of his 
salary, the actual amount to be determined based on the Company's 
performance and Mr. Mahoney's personal performance as determined 
by the Board of Directors or the Compensation Committee of the 
Board of Directors.  He also is entitled to annual stock option 
grants of 50,000 shares during the term of the agreement under the 
Long-Term Plan and may be granted up to 50,000 stock options in 
lieu of a cash bonus in a particular year.

Under the employment agreement, if the Company terminates Mr. 
Mahoney's employment without cause or Mr. Mahoney terminates his 
employment with the Company under a limited set of circumstances 
defined in the employment agreement, including a change of 
control, Mr. Mahoney will receive an amount derived by multiplying 
the factor 2.99 by the sum of his salary and bonus paid in the 
year prior to the year of termination.  In addition, in the event 
of a change in control of the Company, all outstanding stock 
options held by Mr. Mahoney at the time of the change in control 
and which were granted six months or more prior to such time will 
become exercisable in full and will become subject to repurchase, 
at fair market value, for cash by the Company at Mr. Mahoney's 
election.  This agreement also provides that in the event it 
expires and Mr. Mahoney is not rehired in the same position under 
the terms and conditions of a new employment agreement acceptable 
to both Mr. Mahoney and the Company, Mr. Mahoney will receive lump 
sum severance compensation equal to the sum of the salary and 
bonus paid to him in the year ending June 30, 2001, the final year 
of the agreement.  In the event the agreement is terminated by the 
Company for cause, Mr. Mahoney would forfeit any severance payment 
and all of his outstanding stock options.  The agreement also 
provides that upon termination or expiration, Mr. Mahoney's 
participation in Company-sponsored employee and health benefit 
plans will be continued at the Company's expense for a maximum of 
18 months so long as he is alive and is not elsewhere employed or 
self-employed.

Philip S. Present II, the Company's Chief Operating Officer and 
Director, is employed pursuant to an employment agreement dated 
January 1, 1998.  The term of this agreement is 13 months.  The 
agreement provides for a base salary of $15,000 per month, 
beginning in January 1998, plus bonuses payable based upon the 
attainment of certain profitability criteria.  The agreement 
contains customary noncompetition and confidentiality provisions 
and may be terminated by the Company for nonperformance.  In the 
event Mr. Present is elected President of the Company during the 
term of the agreement, whether or not such election follows a 
change in control of the Company, the agreement provides that he 
shall be awarded stock options to purchase 50,000 shares of the 
Company's Common Stock under the Company's Long-Term Stock 
Incentive Plan.  In addition, if the Company terminates Mr. 
Present's employment without cause, he shall receive severance pay 
in the amount of three months' salary.  Finally, should Mr. 
Present's employment be terminated, with or without cause, as a 
result of the liquidation, dissolution, consolidation, merger or 
other business combination of the Company, including the transfer 
of all or substantially all of the Company's assets, the agreement 
provides that (i) the Company shall pay to Mr. Present an amount 
equal to twice the aggregate of salary and bonus payments made to 
him from January 1, 1998 until the date of such termination and 
(ii) all stock options granted to Mr. Present prior to such event 
shall immediately become fully vested (but in no event shall any 
stock options become vested earlier than the minimum vesting 
period provided by the Company's 1994 Long-Term Stock Incentive 
Plan).

Gary L. Price, the Company's Senior Vice President, Business 
Development, is employed pursuant to an employment agreement dated 
March 16, 1998.  The term of this agreement is 6 months and it 
provides for a base salary of $12,000 per month.  The agreement 
contains customary noncompetition and confidentiality provisions 
and may be terminated by the Company for nonperformance.  The 
agreement does not contain any special severance provisions which 
would be triggered by a change in control of the Company.

Timothy P. McMullen, the Company's Vice President of Sales and 
Marketing, is employed pursuant to an employment agreement dated 
January 1, 1998.  The term of this agreement is 13 months.  The 
agreement provides for a base salary of $13,333 per month, 
beginning in January 1998, plus bonuses payable based upon the 
attainment of certain profitability criteria.  The agreement 
contains customary noncompetition and confidentiality provisions 
and may be terminated by the Company for nonperformance.  In the 
event the Company terminates Mr. McMullen's employment without 
cause, he shall receive severance pay in the amount of three 
months' salary.

     Paul F. Albrecht, the Company's Chief Technology Officer, is 
employed pursuant to an employment agreement dated January 1, 
1998.  The term of this agreement is 13 months.  The agreement 
provides for a base salary of $9,167 per month, beginning in 
January 1998, plus bonuses payable based upon the attainment of 
certain revenue and profitability criteria.  The agreement 
contains customary noncompetition and confidentiality provisions 
and may be terminated by the Company for nonperformance. The 
agreement does not contain any special severance provisions which 
would be triggered by a change in control of the Company.

     CERTAIN RELATIONSHIPS, RELATED TRANSACTIONS AND OTHER
                          INFORMATION

     The Company signed a letter of agreement with DiaLogos, Inc. 
("DiaLogos"), dated July 12, 1996, amended January 31, 1997, in 
which the Company, on or before March 31, 1998, agreed to either 
pay DiaLogos for 75% of the common shares of DiaLogos or secure a 
funding commitment for DiaLogos' operations from investors and/or 
lenders, or a combination thereof.  (A copy of such letter of 
agreement was included as an Exhibit to the Company's 1996 Annual 
Report on Form 10-KSB). Certain investors identified by the 
Company would receive a 1% interest in DiaLogos in exchange for 
each $22,000 invested in DiaLogos.  In addition, the letter 
provides that in the event the Company secures a funding 
commitment from investors and/or lenders, then DiaLogos will grant 
the Company the option (immediately exercisable through December 
31, 1999) to purchase 75% of the common shares of DiaLogos less 
any shares already purchased by the Company and/or investors 
identified by the Company.  Richard Mahoney, the President, Chief 
Executive Officer and Chairman of the Board of the Company, Paul 
J. Stein, a director of the Company, Philip S. Present II, the 
Chief Operating Officer and Director of the Company and Daniel A. 
Silber, the Chief Financial Officer of the Company have each 
either invested or agreed to invest funds in DiaLogos in exchange 
for ownership interests therein. Specifically, Mr. Stein has 
executed a promissory note payable to DiaLogos in the amount of 
$44,000 for a 2% interest in DiaLogos, Mr. Mahoney and his spouse 
have invested a total amount of $297,000 for an interest of 13.5% 
of DiaLogos, Mr. Present has invested $44,000 for a 2% interest in 
DiaLogos and Mr. Silber has invested $22,000 for a 1% interest in 
DiaLogos.

     On September 1, 1996, the Company, UDMS and Madison Financial 
Group Ltd. /f/k/a/ DMG Equity Partners LLC ("Madison"), an Ohio 
limited liability company, entered into a Consulting Agreement 
pursuant to which Madison agreed to provide consulting services to 
UDMS in connection with potential acquisitions, corporate 
reorganizations and restructurings, and private or public 
offerings, including preparing reports, memoranda, analyses, and 
other documents for management relating thereto. In consideration 
of the services to be provided by Madison to UDMS thereunder, UDMS 
has paid Madison a one time consulting fee of $50,000 and the 
Company granted Madison a warrant to purchase 15 shares of UDMS 
stock owned by the Company at a price of $415,100, subject to 
adjustment upward in certain circumstances (the "Warrant"). The 
$50,000 fee is to be reimbursed to UDMS in the event Madison 
exercises the Warrant. The Warrant is exercisable for a period of 
three (3) years beginning on the date, if ever, UDMS completes a 
public or private offering of its stock and only if (i) Madison 
does not terminate the Consulting Agreement prior to the 
completion of a public or private offering of UDMS stock and (ii) 
UDMS does not terminate the Consulting Agreement more than ninety 
(90) days prior to completion of a public or private offering of 
UDMS stock.   Richard A. Mahoney, the President, Chief Executive 
Officer and Chairman of the Board of  the Company, holds a 36% 
interest in Madison.

     The Company's Chief Operating Officer and Director, Philip S. 
Present II, was an audit partner with the accounting firm KPMG 
Peat Marwick LLP ("KPMG") prior to joining the Company in 1995.  
In such capacity he served as the engagement partner for a client 
of KPMG, Structural Dynamics Research Corporation ("SDRC"), during 
1993.  In 1995 SDRC restated its financial statements for the 
years 1992 and 1993 as a result of its allegedly having reported 
premature and fictitious revenue for such years.  In April 1997, 
the Securities and Exchange Commission ("SEC") settled a civil 
proceeding in the United States District Court for the Southern 
District of Ohio against SDRC and five of its former senior 
officers.  SDRC consented to a permanent injunction and the former 
officers consented to both permanent injunctions and a total of 
approximately $1.5 million in monetary penalties.  One of the 
former officers also pleaded guilty to related criminal charges.  
In a separate administrative proceeding also concluded in April 
1997, Mr. Present and another former KPMG partner voluntarily 
consented to a cease and desist order arising out of the conduct 
of the audits of SDRC's financial statements without admitting or 
denying any of the SEC's allegations.  As a result of the order, 
Mr. Present may not practice as an accountant before the SEC for a 
period of 30 months.  The order will not affect his current duties 
with the Company or his ability to serve as a director of a 
publicly-held company.  Mr. Present voluntarily consented to the 
order in order to avoid the expense and time burden of prolonged 
contested proceedings.

     The terms of the Agreement of Merger and Plan of 
Reorganization pursuant to which the Company acquired UDMS in 
December 1995 provided that the Company would not sell or merge 
UDMS to or into an unaffiliated third party or sell its stock to 
an unaffiliated third party without the prior consent of  Jay 
Hilnbrand, one of the prior shareholders of UDMS, General Manager 
of UDMS and a director of the Company.  When the Board of 
Directors of the Company determined it would be in the best 
interests of the Company to conduct an initial public offering of 
UDMS' common stock (the "IPO"), the Company needed to obtain Mr. 
Hilnbrand's consent.  In accordance with that obligation, the 
Company and Mr. Hilnbrand entered into an Agreement on May 15, 
1997, subsequently amended December 10, 1997, pursuant to which 
Mr. Hilnbrand agreed to consent to the IPO and the Company agreed 
to pay to Mr. Hilnbrand $10,100 on the effective date of the IPO. 
 (A copy of this Agreement, as amended, was included as an Exhibit 
to the Company's 1998 Annual Report on Form 10-KSB.)

  When the Company acquired UDMS in December 1995, it also 
acquired all the common stock of HWB, Inc., a company which was 
affiliated with UDMS and of which Mr. Hilnbrand was a shareholder 
("HWB").  A portion of the consideration paid by the Company for 
the common stock of HWB was to be based on the revenues of UDMS 
over a period of time (the "Earn-Out Consideration").  As a result 
of the potential IPO, the Company and Mr. Hilnbrand have also 
amended the Stock Purchase Agreement dated December 29, 1995 
pursuant to which Mr. Hilnbrand sold to the Company all of the 
common stock of HWB, Inc. owned by  him.  (A copy of this 
Agreement, as amended, was included as an Exhibit to the Company's 
1998 Annual Report on Form 10-KSB).  The amendment provides that 
if the IPO occurs, certain Earn-Out Consideration due Hilnbrand 
could be earned by him over an extended period of time and a 
portion of such consideration could be paid in the form of UDMS' 
common stock instead of the Company's common stock.

In January 1998, the Company decided to sell the net assets of the 
Step2000 segment of UDMS and is currently negotiating with 
prospective buyers.  The Company expects to complete the sale by 
the end of December 1998.  Jay Hilnbrand, General Manager of UDMS 
and a director of the Company, has been acting on the Company's 
behalf in identifying and negotiating with prospective buyers.  It 
is the intention of the Company to compensate Mr. Hilnbrand for 
these efforts in the event the Company sells the Step2000 product 
as a result of such efforts.  At this time, the specific terms of 
such compensation have not been finalized.

                      1999 SHAREHOLDER PROPOSALS

In order for any shareholder proposals for the 1999 Annual Meeting 
of Shareholders to be eligible for inclusion at the meeting, they 
must be received by the Secretary of the Company at 8805 
Governor's Hill Drive, Suite 100, Cincinnati, Ohio 45249, prior to 
December 28, 1998.

           SELECTION OF ACCOUNTANTS FOR FISCAL YEAR 1999

The Company will continue to retain the services of KPMG Peat 
Marwick LLP, its outside accounting firm since 1994, for fiscal 
year 1999.  Representatives of KPMG Peat Marwick LLP are expected 
to be present at the Annual Meeting, will have the opportunity to 
make a statement if they desire to do so and are expected to be 
available to respond to appropriate questions.

                            OTHER MATTERS

The Board of Directors does not know of any other business to be 
presented to the meeting and does not intend to bring other 
matters before the meeting.  However, if other matters properly 
come before the meeting, it is intended that the persons named in 
the accompanying proxy will vote thereon according to their best 
judgment in the interests of the Company.

By Order of the Board of Directors


Robert E. Kenny III
Secretary




EXHIBIT A
_____________________

MEDPLUS, INC. EMPLOYEE STOCK PURCHASE PLAN
ARTICLE I -- PURPOSE

1.01. Purpose

The MedPlus, Inc. Employee Stock Purchase Plan (the "Plan") is 
intended to  provide a method whereby Employees of MedPlus, Inc. 
and its Subsidiary  Corporations (hereinafter referred to, unless 
the context otherwise requires,  as the "Company") will have an 
opportunity to acquire a proprietary interest  in the Company 
through the purchase of shares of the Common Stock of the  
Company. It is the intention of the Company to have the Plan 
qualify as an  "employee stock purchase plan" under Section 423 of 
the Internal Revenue Code  of 1986, as amended (the "Code"). The 
provisions of the Plan shall be  construed so as to extend and 
limit participation in a manner consistent with  the requirements 
of that Section of the Code. 

ARTICLE II -- DEFINITIONS

2.01. Base Pay

"Base Pay" means regular straight-time earnings excluding payments 
for  overtime, shift premium, bonuses and other special payments, 
commissions and  other marketing incentive payments. 

2.02. Committee

"Committee" means the individuals described in Article XI.

2.03. Employee

"Employee" means any person who is customarily employed on a full-
time or part-time basis by the Company and is regularly scheduled 
to work more than 20 hours per week.

2.04.  Offering

"Offering" means each of the annual or six-month offerings of the 
Company's Common Stock under the Plan.

2.05.  Offering Commencement Date

"Offering Commencement Date" means the August 1 or February 1, as 
the case may be, on which the particular Offering begins.


2.06.  Offering Termination Date

"Offering Termination Date" means the January 31 or July 31, as 
the case may be, on which the particular Offering terminates.

2.07. Subsidiary Corporation

"Subsidiary Corporation" means any present or future corporation 
which (i) is a "subsidiary corporation", as that term is defined 
in Section 424 of the Code, of the Company and (ii) is designated 
by the Committee as an entity the employees of which shall be 
entitled to participate in the Plan.

ARTICLE III -- ELIGIBILITY AND PARTICIPATION

3.01. Initial Eligibility.

Any Employee who shall have completed 90 days' employment and 
shall be  employed by the Company on the date his participation in 
the Plan is to become  effective shall be eligible to participate 
in Offerings under the Plan which  commence on or after such 90 
day period has concluded. 

3.02. Leave of Absence.

For purposes of participation in the Plan, a person on leave of 
absence shall  be deemed to be an Employee for the first 90 days 
of such leave of absence and  such Employee's employment shall be 
deemed to have terminated at the close of  business on the 90th 
day of such leave of absence unless such Employee shall  have 
returned to regular full-time or part-time employment (as the case 
may  be) prior to the close of business on such 90th day. 
Termination by the  Company of any Employee's leave of absence, 
other than termination of such  leave of absence on return to 
full-time or part-time employment, shall  terminate an Employee's 
employment for all purposes of the Plan and shall  terminate such 
Employee's participation in the Plan and right to exercise any  
option.  3.03. Restrictions on Participation.  Notwithstanding any 
provisions of the Plan to the contrary, no Employee shall  be 
granted an option to participate in the Plan:  

(a) if, immediately after the grant, such Employee would own 
stock, and/or hold outstanding options to purchase stock, 
possessing 5% or more of the total combined voting power or value 
of all classes of stock of the Company (for purposes of this 
paragraph, the rules of Section 424(d) of the Code shall apply in 
determining stock ownership of any Employee); or

(b) which permits his rights to purchase stock under all Code Sec. 
423 employee stock purchase plans of the Company to accrue at a 
rate which exceeds $25,000 in fair market value of the stock 
(determined at the time such option is granted) for each calendar 
year in which such option is outstanding.

3.04. Commencement of Participation.

An eligible Employee may become a participant by completing an 
authorization for a payroll deduction on the form provided by the 
Company and filing it with the Committee on or before the date set 
therefor by the Committee, which date shall be prior to the 
Offering Commencement Date for the Offering.  Payroll deductions 
for a participant shall commence on the applicable Offering 
Commencement Date when his authorization for a payroll deduction 
becomes effective and shall end on the Offering Termination Date 
of the Offering to which such authorization is applicable unless 
sooner terminated by the participant as provided in Article VIII.

ARTICLE IV -- OFFERINGS

4.01. Annual Offerings.

The Plan will be implemented by four annual Offerings of the 
Company's Common Stock beginning on the 1st day of August in each 
of the years 1998, 1999, 2000 and 2001, each Offering terminating 
on July 31 of the following year, provided, however, that each 
annual Offering may, in the discretion of the Committee exercised 
prior to the commencement thereof, be divided into two six-month 
Offerings commencing, respectively, on August 1 of such year and 
February 1 of the following year and terminating on January 31 and 
July 31 of the following year, respectively. The maximum number of 
shares issued in the respective years shall be:

- - From August 1, 1998 to July 31, 1999:  50,000 shares.

- - From August 1, 1999 to July 31, 2000: 75,000 shares plus 
unissued shares from the prior Offerings, whether offered or not.

- - From August 1, 2000 to July 31, 2001: 100,000 shares plus 
unissued shares from the prior Offerings, whether offered or not.

- - From August 1, 2001 to July 31, 2002: 125,000 shares plus 
unissued shares from the prior Offerings, whether offered or not.

If a six-month Offering is made, the maximum number of shares to 
be issued  shall be one-half of the number of shares set forth for 
the annual period in  which the six-month Offering falls, plus, if 
the Offering is a February 1 to  July 31 Offering, unissued 
shares, whether offered or not, from the  immediately preceding 
six-month Offering.  

	ARTICLE V -- PAYMENTS FOR STOCK

5.01.  Method of Payment.

Unless otherwise determined by the Committee, the method of 
contribution to  the Plan shall be by regular payroll deduction as 
provided below.  The  Committee shall have the authority to 
establish such other methods of  contribution to the Plan as it 
deems reasonable and appropriate under the  circumstances. 

5.02. Amount of Deduction.

At the time a participant files his authorization for payroll 
deduction, he  shall elect to have deductions made from his pay on 
each payday during the  time he is a participant in an Offering at 
the rate of 1% to 10%, in  increments of 1%, of his Base Pay in 
effect at the Offering Commencement Date  of such Offering. In the 
case of a part-time hourly Employee, such Employee's  Base Pay 
during an Offering shall be determined by multiplying such 
Employee's  hourly rate of pay in effect on the Offering 
Commencement Date by the number  of regularly scheduled hours of 
work for such Employee during such Offering.

5.03. Participant's Account.

All payroll deductions made for a participant shall be credited to 
his account  under the Plan. A participant may not make any 
separate cash payment into such  account except when on leave of 
absence and then only as provided in Section  5.04. 

5.04. Changes in Payroll Deductions.

A participant may discontinue his participation in the Plan as 
provided in  Article VIII, but no other change can be made during 
an Offering and,  specifically, a participant may not alter the 
amount of his payroll deductions  for that Offering.

5.05. Leave of Absence.

If a participant goes on a leave of absence, such participant 
shall have the  right to elect: (a) to withdraw the balance in his 
or her account pursuant to  Section 7.02, (b) to discontinue 
contributions to the Plan but remain a  participant in the Plan, 
or remain a participant in the Plan during such leave  of absence, 
authorizing deductions to be made from payments by the Company to  
the participant during such leave of absence and undertaking to 
make cash  payments to the Plan at the end of each payroll period 
to the extent that  amounts payable by the Company to such 
participant are insufficient to meet  such participant's 
authorized Plan deductions.


ARTICLE VI -- GRANTING OF OPTION

6.01. Number of Option Shares.

On the Commencement Date of each Offering, a participating 
Employee shall be  deemed to have been granted an option to 
purchase a maximum number of shares  of the stock of the Company 
equal to an amount determined as follows: an  amount equal to (i) 
that percentage of the Employee's Base Pay which he has  elected 
to have withheld (but not in any case in excess of 10%) multiplied 
by  (ii) the Employee's Base Pay during the period of the Offering 
and divided by  (iii) 85% of the market value of the stock of the 
Company on the applicable  Offering Commencement Date. The market 
value of the Company's stock shall be  determined as provided in 
paragraphs (a) and (b) of Section 6.02 below. An  Employee's Base 
Pay during the period of an Offering shall be determined by  
multiplying, in the case of a one-year Offering, his normal weekly 
rate of pay  (as in effect on the last day prior to the 
Commencement Date of the particular  Offering) by 52 or the hourly 
rate by 2,080 or, in the case of a six-month  Offering, by 26 or 
1040, as the case may be, provided that, in the case of a  part-
time hourly Employee, the Employee's Base Pay during the period of 
an  Offering shall be determined by multiplying such Employee's 
hourly rate by the  number of regularly scheduled hours of work 
for such Employee during such  Offering. 

6.02. Option Price.

The option price of stock purchased with payroll deductions made 
during such Offerings for a participant therein shall be the lower 
of:

(a) 85% of the closing price of the stock on the Offering 
Commencement Date or the nearest prior business day on which 
trading occurred on the Nasdaq National Market; or

(b) 85% of the closing price of the stock on the Offering 
Termination Date or the nearest prior business day on which 
trading occurred on the Nasdaq National Market.

ARTICLE VII -- EXERCISE OF OPTION

7.01. Automatic Exercise.

Unless a participant gives written notice to the Company as 
hereinafter provided, his option for the purchase of stock with 
payroll deductions made during any Offering will be deemed to have 
been exercised automatically on the Offering Termination Date 
applicable to such Offering, for the purchase of the number of 
full shares of stock which the accumulated payroll deductions in 
his account at that time will purchase at the applicable option 
price (but not in excess of the number of shares for which options 
have been granted to the  Employee pursuant to Section 6.01), and 
any excess in his account at that time  will be returned to him.   

7.02. Withdrawal of Account.  

By written notice to the Committee, at any time prior to the 
Offering  Termination Date applicable to any Offering, a 
participant may elect to  withdraw all the accumulated payroll 
deductions in his account at such time.  

7.03. Fractional Shares.  

Fractional shares will not be issued under the Plan and any 
accumulated  payroll deductions which would have been used to 
purchase fractional shares  will be returned to any Employee 
promptly following the termination of an  Offering, without 
interest. 

7.04. Transferability of Option.  

During a participant's lifetime, options held by such participant 
shall be  exercisable only by that participant.  

7.05.  Delivery of Stock.  

As promptly as practicable after the Offering Termination Date of 
each  Offering, the Company will deliver to each participant, as 
appropriate, the  stock purchased upon exercise of his option.  

ARTICLE VIII -- WITHDRAWAL 

8.01. In General.  

As indicated in Section 7.02, a participant may withdraw payroll 
deductions  credited to his account under the Plan at any time by 
giving written notice to  the Committee.  All of the participant's 
payroll deductions credited to his  account will be paid to him 
promptly after receipt of his notice of  withdrawal, and no 
further payroll deductions will be made from his pay during  such 
Offering. The Company may, at its option, treat any attempt to 
borrow by  an Employee on the security of his accumulated payroll 
deductions as an  election, under Section 3.02, to withdraw such 
deductions.  

8.02. Effect on Subsequent Participation.  

A participant's withdrawal from any Offering will not have any 
effect upon his  eligibility to participate in any succeeding 
Offering or in any similar plan  which may hereafter be adopted by 
the Company.   

8.03. Termination of Employment.  

Upon termination of the participant's employment for any reason, 
including  retirement (but excluding death while in the employ of 
the Company or  continuation of a leave of absence for a period 
beyond 90 days), the payroll  deductions credited to his account 
will be returned to him, or, in the case of  his death subsequent 
to the termination of his employment, to the person or  persons 
entitled thereto under Section 12.01.  

8.04. Termination of Employment Due to Death.  

Upon termination of the participant's employment because of his 
death, his  beneficiary (as defined in Section 12.01) shall have 
the right to elect, by  written notice given to the Committee  
prior to the earlier of the Offering  Termination Date or the 
expiration of a period of 60 days commencing with the  date of the 
death of the participant, either:  (a) to withdraw all of the 
payroll deductions credited to the participant's  account under 
the Plan, or  (b) to exercise the participant's option for the 
purchase of stock on the  Offering Termination Date next following 
the date of the participant's death  for the purchase of the 
number of full shares of stock which the accumulated  payroll 
deductions in the participant's account at the date of the  
participant's death will purchase at the applicable option price, 
and any  excess in such account will be returned to said 
beneficiary, without interest.  In the event that no such written 
notice of election shall be duly received by  the Committee, the 
beneficiary shall automatically be deemed to have elected,  
pursuant to paragraph (b), to exercise the participant's option.  

8.05. Leave of Absence.  

A participant on leave of absence shall, subject to the election 
made by such  participant pursuant to Section 5.04, continue to be 
a participant in the Plan  so long as such participant is on 
continuous leave of absence. A participant  who has been on leave 
of absence for more than 90 days and who therefore is  not an 
Employee for the purpose of the Plan shall not be entitled to  
participate in any Offering commencing after the 90th day of such 
leave of  absence. Notwithstanding any other provisions of the 
Plan, unless a  participant on leave of absence returns to regular 
full-time or part-time  employment with the Company at the earlier 
of: (a) the termination of such  leave of absence or (b) three 
months from the 90th day of such leave of  absence, such 
participant's participation in the Plan shall terminate on  
whichever of such dates first occurs.  

ARTICLE IX -- INTEREST 

9.01. Payment of Interest.  

No interest will be paid or allowed on any money paid into the 
Plan or  credited to the account of any participant Employee.  

ARTICLE X -- STOCK 

10.01. Maximum Shares.  

The maximum number of shares which shall be issued under the Plan, 
subject to  adjustment upon changes in capitalization of the 
Company as provided in  Section 12.04 shall be 125,000 shares in 
each annual Offering (62,500 shares  in each six-month Offering) 
plus in each Offering all unissued shares from  prior Offerings, 
whether offered or not, not to exceed 350,000 shares for all  
Offerings. If the total number of shares for which options are 
exercised on  any Offering Termination Date in accordance with 
Article VI exceeds the  maximum number of shares for the 
applicable Offering, the Company shall make a  pro rata allocation 
of the shares available for delivery and distribution, and  the 
balance of payroll deductions credited to the account of each 
participant  under the Plan shall be returned to him as promptly 
as possible.  

10.02. Participant's Interest in Option Stock.  

The participant will have no interest in stock covered by his 
option until  such option has been exercised. 

10.03. Registration of Stock.  

Stock to be delivered to a participant under the Plan will be 
registered in  the name of the participant, or, if the participant 
so directs by written  notice to the Committee prior to the 
Offering Termination Date applicable  thereto, in the names of the 
participant and one such other person as may be  designated by the 
participant, as joint tenants with rights of survivorship or  as 
tenants by the entireties, to the extent permitted by applicable 
law.  

10.04. Restrictions on Exercise.  

The Board of Directors may, in its discretion, require as 
conditions to the  exercise of any option that the shares of 
Common Stock reserved for issuance  upon the exercise of the 
option shall have been duly listed, upon official  notice of 
issuance, upon a stock exchange, and that either:   (a) a 
Registration Statement under the Securities Act of 1933, as 
amended,  with respect to said shares shall be effective, or  (b) 
the participant shall have represented at the time of purchase, in 
form  and substance satisfactory to the Company, that it is his 
intention to  purchase the shares for investment and not for 
resale or distribution.  

ARTICLE XI -- ADMINISTRATION 

11.01. Appointment of Committee.   

The Board of Directors shall appoint a committee (the "Committee") 
to  administer the Plan, which shall consist of no fewer than 
three members of the  Board of Directors.  No member of the 
Committee shall be eligible to purchase  stock under the Plan.  

11.02. Authority of Committee. 

Subject to the express provisions of the Plan, the Committee shall 
have  plenary authority in its discretion to interpret and 
construe any and all  provisions of the Plan, to adopt rules and 
regulations for administering the  Plan, and to make all other 
determinations deemed necessary or advisable for  administering 
the Plan. The Committee's determination on the foregoing matters  
shall be conclusive.  

11.03. Rules Governing the Administration of the Committee.  

The Board of Directors may from time to time appoint members of 
the Committee  in substitution for or in addition to members 
previously appointed and may  fill vacancies, however caused, in 
the Committee. The Committee may select one  of its members as its 
Chairman and shall hold its meetings at such times and  places as 
it shall deem advisable. A majority of its members shall 
constitute  a quorum. All determinations of the Committee shall be 
made by a majority of  its members. The Committee may correct any 
defect or omission or reconcile any  inconsistency in the Plan in 
the manner and to the extent it shall deem  desirable. Any 
decision or determination reduced to writing and signed by a  
majority of the members of the Committee shall be as fully 
effective as if it  had been made by a majority vote at a meeting 
duly called and held. The  Committee may appoint a secretary and 
shall make such rules and regulations  for the conduct of its 
business as it shall deem advisable.  	

ARTICLE XII -- MISCELLANEOUS 

12.01. Designation of Beneficiary.   

A participant may file a written designation of a beneficiary who 
is to  receive any stock and/or cash. Such designation of 
beneficiary may be changed  by the participant at any time by 
written notice to the Committee.  Upon the  death of a participant 
and upon receipt by the Company of proof of identity  and 
existence at the participant's death of a beneficiary validly 
designated  by him under the Plan, the Company shall deliver such 
stock and/or cash to  such beneficiary. In the event of the death 
of a participant and in the  absence of a beneficiary validly 
designated under the Plan who is living at  the time of such 
participant's death, the Company shall deliver such stock  and/or 
cash to the executor or administrator of the estate of the 
participant,  or if no such executor or administrator has been 
appointed (to the knowledge  of the Company), the Company, in its 
discretion, may deliver such stock and/or  cash to the spouse or 
to any one or more dependents of the participant as the  Company 
may designate. No beneficiary shall, prior to the death of the  
participant by whom he has been designated, acquire any interest 
in the stock  or cash credited to the participant under the Plan.  

12.02. Transferability.  

Neither payroll deductions credited to a participant's account nor 
any rights  with regard to the exercise of an option or to receive 
stock under the Plan  may be assigned, transferred, pledged, or 
otherwise disposed of in any way by  the participant other than by 
will or the laws of descent and distribution.  Any such attempted 
assignment, transfer, pledge or other disposition shall be  
without effect, except that the Company may treat such act as an 
election to  withdraw funds in accordance with Section 7.02.  

12.03. Use of Funds.  

All payroll deductions received or held by the Company under this 
Plan may be  used by the Company for any corporate purpose and the 
Company shall not be  obligated to segregate such payroll 
deductions.  

12.04. Adjustment Upon Changes in Capitalization.  

(a) If, while any options are outstanding, the outstanding shares 
of Common  Stock of the Company have increased, decreased, changed 
into, or been  exchanged for a different number or kind of shares 
or securities of the  Company through reorganization, merger, 
recapitalization, reclassification,  stock split, reverse stock 
split or similar transaction, appropriate and  proportionate 
adjustments may be made by the Committee in the number and/or  
kind of shares which are subject to purchase under outstanding 
options and on  the option exercise price or prices applicable to 
such outstanding options. In  addition, in any such event, the 
number and/or kind of shares which may be  offered in the 
Offerings described in Article IV hereof shall also be  
proportionately adjusted. No adjustments shall be made for stock 
dividends.  For the purposes of this Paragraph, any distribution 
of shares to shareholders  in an amount aggregating 20% or more of 
the outstanding shares shall be deemed  a stock split and any 
distributions of shares aggregating less than 20% of the  
outstanding shares shall be deemed a stock dividend.   

(b) Upon the dissolution or liquidation of the Company, or upon a  
reorganization, merger or consolidation of the Company with one or 
more  corporations as a result of which the Company is not the 
surviving  corporation, or upon a sale of substantially all of the 
property or stock of  the Company to another corporation, the 
holder of each option then outstanding  under the Plan will 
thereafter be entitled to receive at the next Offering  
Termination Date upon the exercise of such option for each share 
as to which  such option shall be exercised, as nearly as 
reasonably may be determined, the  cash, securities and/or 
property which a holder of one share of the Common  Stock was 
entitled to receive upon and at the time of such transaction. The  
Board of Directors shall take such steps in connection with such 
transactions  as the Board shall deem necessary to assure that the 
provisions of this  Section 12.04 shall thereafter be applicable, 
as nearly as reasonably may be  determined, in relation to the 
said cash, securities and/or property as to  which such holder of 
such option might thereafter be entitled to receive.  

12.05. Amendment and Termination.  

The Board of Directors shall have complete power and authority to 
terminate or  amend the Plan; provided, however, that the Board of 
Directors shall not,  without the approval of the stockholders of 
the Corporation (i) increase the  maximum number of shares which 
may be issued under any Offering (except  pursuant to Section 
12.04); (ii) amend the requirements as to the class of  employees 
eligible to purchase stock under the Plan or (iii) permit the  
members of the Committee to purchase stock under the Plan. No 
termination,  modification, or amendment of the Plan may, without 
the consent of an Employee  then having an option under the Plan 
to purchase stock, adversely affect the  rights of such Employee 
under such option.  

12.06. Effective Date.   

The Plan shall become effective as of August 1, 1998 if approved 
by the  holders of a majority of the Common Stock present in 
person or by proxy at a  special or annual meeting of the 
shareholders held on or before June 30, 1998.  If the Plan is not 
so approved, the Plan shall not become effective.  

12.07. No Employment Rights.  

The Plan does not, directly or indirectly, create any right for 
the benefit of  any Employee or class of employees to purchase any 
shares under the Plan, or  create in any Employee or class of 
employees any right with respect to  continuation of employment by 
the Company, and it shall not be deemed to  interfere in any way 
with the Company's right to terminate, or otherwise  modify, an 
Employee's employment at any time.  

12.08. Effect of Plan.  

The provisions of the Plan shall, in accordance with its terms, be 
binding  upon, and inure to the benefit of, all successors of each 
Employee  participating in the Plan, including, without 
limitation, such Employee's  estate and the executors, 
administrators or trustees thereof, heirs and  legatees, and any 
receiver, trustee in bankruptcy or representative of  creditors of 
such Employee.   12.09. Governing Law.  The law of the State of 
Ohio will govern all matters relating to this Plan  except to the 
extent it is superseded by the laws of the United States.    

MEDPLUS, INC.     

FORM OF PROXY
______________________

MedPlus, Inc.
8805 Governor's Hill Drive
Cincinnati, OH  45249

THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS.

   The undersigned hereby appoints Richard A. Mahoney and Robert 
E. Kenny III and each of them with full power of substitution as 
proxies to vote, as designated below, for and in the name of the 
undersigned all shares of stock of MedPlus, Inc. which the 
undersigned is entitled to vote at the Annual Meeting of the 
Shareholders of said Company scheduled to be held on June 25, 1998 
at 1:30 p.m. at the Blue Ash Hotel and Conference Center, 5901 
Pfeiffer Road, Cincinnati, Ohio, 45242 or at any adjournment or 
recess thereof.

   Please mark X in the appropriate box.  The Board of Directors 
recommends a FOR vote on each proposal.

1. ELECTION OF DIRECTORS.

    FOR all nominees listed below.    _______WITHHOLD AUTHORITY
(except as marked to the 
contrary below)

RICHARD A. MAHONEY, ROBERT E. KENNY III, PAUL J. STEIN,
JAY HILNBRAND, PAUL A. MARTIN, PHILIP S. PRESENT II

2. APPROVAL OF AN AMENDMENT TO THE 1994 LONG-TERM STOCK INCENTIVE 
PLAN INCREASING THE TOTAL NUMBER OF SHARES OF THE COMPANY'S COMMON 
STOCK SUBJECT TO GRANTS THEREUNDER FROM 1 MILLION SHARES TO 2 
MILLION SHARES.
 
   FOR approval of the amendment.     ________ WITHHOLD AUTHORITY

3. APPROVAL OF THE MEDPLUS, INC. EMPLOYEE STOCK PURCHASE PLAN

    FOR approval of the Plan.         ________ WITHHOLD AUTHORITY


4. In their discretion, the proxies are authorized to vote upon 
such other business as may properly come before the meeting or any 
adjournment thereof.

ALL FORMER PROXIES ARE HEREBY REVOKED.

                              NUMBER OF SHARES _______________
                               ________________________________
                              (Signature of Shareholder)
                               ________________________________
                              (Signature of Shareholder)

                                 Please sign exactly as your name 
                                 appears to the left.  All joint 
                                 owners should sign.  (When 
                                 signing in a fiduciary capacity 
                                 or as a corporate officer, please 
                                 give your full title as such.)

                                 Dated: _________________, 1998
            








© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission